石四药集团：盐酸去氧肾上腺素获批上市，应对低血压治疗

和讯网07-23

快讯正文【石四药集团宣布，其盐酸去氧肾上腺素已获中国国家药品监督管理局批准，成为在上市制剂使用的原料药。】石四药集团近日公告，其研发的盐酸去氧肾上腺素已正式获得中国国家药品监督管理局的批准登记。该药物主要用于治疗麻醉过程中因血管扩张导致的低血压症状。这一进展标志着石四药集团在药品原料药领域取得了重要突破，预计将增强公司在相关药品市场的。投资者和市场分析师将密切关注这一批准对石四药集团未来业绩的潜在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2453208114?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-23 17:45","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2453208114","market":"hk","top_or_hot":-1,"title":"石四药集团：盐酸去氧肾上腺素获批上市，应对低血压治疗","media":"和讯网","content":"<div>\n<p>快讯正文【石四药集团宣布，其盐酸去氧肾上腺素已获中国国家药品监督管理局批准，成为在上市制剂使用的原料药。】石四药集团近日公告，其研发的盐酸去氧肾上腺素已正式获得中国国家药品监督管理局的批准登记。该药物主要用于治疗麻醉过程中因血管扩张导致的低血压症状。这一进展标志着石四药集团在药品原料药领域取得了重要突破，预计将增强公司在相关药品市场的。投资者和市场分析师将密切关注这一批准对石四药集团未来业绩的潜在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231808079ee23dfc&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>石四药集团：盐酸去氧肾上腺素获批上市，应对低血压治疗</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n石四药集团：盐酸去氧肾上腺素获批上市，应对低血压治疗\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-23 17:45 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231808079ee23dfc&s=b><strong>和讯网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>快讯正文【石四药集团宣布，其盐酸去氧肾上腺素已获中国国家药品监督管理局批准，成为在上市制剂使用的原料药。】石四药集团近日公告，其研发的盐酸去氧肾上腺素已正式获得中国国家药品监督管理局的批准登记。该药物主要用于治疗麻醉过程中因血管扩张导致的低血压症状。这一进展标志着石四药集团在药品原料药领域取得了重要突破，预计将增强公司在相关药品市场的。投资者和市场分析师将密切关注这一批准对石四药集团未来业绩的潜在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231808079ee23dfc&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231808079ee23dfc&s=b","article_id":"2453208114","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231808079ee23dfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2453208114","pubTimestamp":1721727945,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"快讯正文【石四药集团宣布，其盐酸去氧肾上腺素已获中国国家药品监督管理局批准，成为在上市制剂使用的原料药。】石四药集团近日公告，其研发的盐酸去氧肾上腺素已正式获得中国国家药品监督管理局的批准登记。该药物主要用于治疗麻醉过程中因血管扩张导致的低血压症状。这一进展标志着石四药集团在药品原料药领域取得了重要突破，预计将增强公司在相关药品市场的。投资者和市场分析师将密切关注这一批准对石四药集团未来业绩的潜在影响，以及其在二级市场上的股价反应。下载和讯APP查看快讯，体验更佳>>","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1191":"制药","02005":"石四药集团"},"translate_title":"Shisi Pharmaceutical Group: Phenylephrine Hydrochloride Approved for Marketing to Treat Hypotension","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02005":1},"content_text":"快讯正文【石四药集团宣布，其盐酸去氧肾上腺素已获中国国家药品监督管理局批准，成为在上市制剂使用的原料药。】石四药集团近日公告，其研发的盐酸去氧肾上腺素已正式获得中国国家药品监督管理局的批准登记。该药物主要用于治疗麻醉过程中因血管扩张导致的低血压症状。这一进展标志着石四药集团在药品原料药领域取得了重要突破，预计将增强公司在相关药品市场的。投资者和市场分析师将密切关注这一批准对石四药集团未来业绩的潜在影响，以及其在二级市场上的股价反应。下载和讯APP查看快讯，体验更佳>>","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2453208114"}